A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Renaissance Technologies LLC holds 2,574,546 shares of NBIX stock, worth $317 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares
2,574,546
Previous 2,468,146 4.31%
Holding current value
$317 Million
Previous $340 Million 12.77%
% of portfolio
0.47%
Previous 0.6%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$114.58 - $153.15 $12.2 Million - $16.3 Million
106,400 Added 4.31%
2,574,546 $296 Million
Q2 2024

Aug 09, 2024

BUY
$130.86 - $143.19 $28.3 Million - $31 Million
216,500 Added 9.62%
2,468,146 $340 Million
Q1 2024

May 13, 2024

BUY
$130.4 - $143.74 $34.3 Million - $37.8 Million
263,100 Added 13.23%
2,251,646 $311 Million
Q4 2023

Feb 13, 2024

BUY
$106.07 - $132.76 $42.3 Million - $52.9 Million
398,382 Added 25.05%
1,988,546 $262 Million
Q3 2023

Nov 14, 2023

SELL
$94.02 - $117.1 $5.01 Million - $6.23 Million
-53,238 Reduced 3.24%
1,590,164 $179 Million
Q2 2023

Aug 11, 2023

SELL
$89.53 - $104.87 $27.2 Million - $31.8 Million
-303,662 Reduced 15.6%
1,643,402 $155 Million
Q1 2023

May 12, 2023

BUY
$94.11 - $123.02 $31.4 Million - $41 Million
333,400 Added 20.66%
1,947,064 $197 Million
Q4 2022

Feb 13, 2023

BUY
$106.72 - $127.06 $18.3 Million - $21.8 Million
171,200 Added 11.87%
1,613,664 $193 Million
Q3 2022

Nov 14, 2022

SELL
$92.03 - $107.81 $603,624 - $707,125
-6,559 Reduced 0.45%
1,442,464 $153 Million
Q2 2022

Aug 12, 2022

BUY
$75.79 - $100.07 $12.8 Million - $16.9 Million
168,900 Added 13.19%
1,449,023 $141 Million
Q1 2022

May 13, 2022

SELL
$72.45 - $94.81 $10.4 Million - $13.6 Million
-143,541 Reduced 10.08%
1,280,123 $120 Million
Q4 2021

Feb 11, 2022

BUY
$79.65 - $106.22 $5.39 Million - $7.19 Million
67,700 Added 4.99%
1,423,664 $121 Million
Q3 2021

Nov 12, 2021

BUY
$86.18 - $99.03 $9.76 Million - $11.2 Million
113,241 Added 9.11%
1,355,964 $130 Million
Q2 2021

Aug 13, 2021

SELL
$89.43 - $102.27 $13.9 Million - $15.9 Million
-155,141 Reduced 11.1%
1,242,723 $121 Million
Q1 2021

May 13, 2021

SELL
$87.57 - $119.4 $35.8 Million - $48.9 Million
-409,327 Reduced 22.65%
1,397,864 $136 Million
Q4 2020

Feb 10, 2021

SELL
$86.91 - $108.33 $29.7 Million - $37.1 Million
-342,273 Reduced 15.92%
1,807,191 $173 Million
Q3 2020

Nov 13, 2020

BUY
$96.16 - $135.15 $63.9 Million - $89.8 Million
664,700 Added 44.77%
2,149,464 $207 Million
Q2 2020

Aug 13, 2020

BUY
$85.09 - $130.36 $65.1 Million - $99.8 Million
765,382 Added 106.39%
1,484,764 $181 Million
Q1 2020

May 14, 2020

SELL
$75.11 - $113.76 $1.49 Million - $2.25 Million
-19,790 Reduced 2.68%
719,382 $62.3 Million
Q4 2019

Feb 13, 2020

BUY
$86.8 - $118.57 $63.8 Million - $87.2 Million
735,272 Added 18853.13%
739,172 $79.5 Million
Q3 2019

Nov 13, 2019

SELL
$83.82 - $101.5 $950,602 - $1.15 Million
-11,341 Reduced 74.41%
3,900 $351,000
Q2 2019

Aug 12, 2019

SELL
$72.24 - $91.27 $15.4 Million - $19.4 Million
-212,700 Reduced 93.31%
15,241 $1.29 Million
Q1 2019

May 14, 2019

BUY
$69.31 - $91.53 $10.5 Million - $13.9 Million
152,100 Added 200.55%
227,941 $20.1 Million
Q4 2018

Feb 13, 2019

BUY
$68.32 - $124.36 $5.18 Million - $9.43 Million
75,841 New
75,841 $5.42 Million

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.8B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.